The Kidney Research Network (KRN) was founded  in 2015 to strategically focus patients, clinicians, scientists and public and private partners to advance safe and effective therapies to patients affected by proteinuric kidney diseases.  In 2023 the network expanded to include all forms of kidney disease.

 

The program is supported by a Patient Advisory Board and consists of a multi-site EHR Registry, Data Warehouse and Analysis Team, and Endpoints & Outcomes Consortium

​

The KRN uses quality initiatives, health education, clinical trials, and collaborative partnerships to achieve its goals.